Literature DB >> 28093932

Involvement of p53 and Bcl-2 in sensory cell degeneration in aging rat cochleae.

Yang Xu1, Wei Ping Yang2,3, Bo Hua Hu2, Shiming Yang3, Donald Henderson2.   

Abstract

CONCLUSION: p53 and Bcl-2 (B-cell lymphoma 2) are involved in the process of sensory cell degeneration in aging cochleae.
OBJECTIVE: To determine molecular players in age-related hair cell degeneration, this study examined the changes in p53 and Bcl-2 expression at different stages of apoptotic and necrotic death of hair cells in aging rat cochleae.
METHODS: Young (3-4 months) and aging (23-24 months) Fisher 344/NHsd rats were used. The thresholds of the auditory brainstem response (ABR) were measured to determine the auditory function. Immunolabeling was performed to determine the expression of p53 and Bcl-2 proteins in the sensory epithelium. Propidium iodide staining was performed to determine the morphologic changes in hair cell nuclei.
RESULTS: Aging rats exhibited a significant elevation in ABR thresholds at all tested frequencies (p < 0.001). The p53 and Bcl-2 immunoreactivity was increased in aging hair cells showing the early signs of apoptotic changes in their nuclei. The Bcl-2 expression increase was also observed in hair cells displaying early signs of necrosis. As the hair cell degenerative process advanced, p53 and Bcl-2 immunoreactivity became reduced or absent. In the areas where no detectable nuclear staining was present, p53 and Bcl-2 immunoreactivity was absent.

Entities:  

Keywords:  Bcl-2; aging; apoptosis; hair cell; necrosis; p53; rat

Mesh:

Substances:

Year:  2017        PMID: 28093932     DOI: 10.1080/00016489.2016.1274425

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  1 in total

1.  PINK1 Protects Against Gentamicin-Induced Sensory Hair Cell Damage: Possible Relation to Induction of Autophagy and Inhibition of p53 Signal Pathway.

Authors:  Qianqian Yang; Yiwei Zhou; Haiyan Yin; Hongrui Li; Meijuan Zhou; Gaoying Sun; Zhixin Cao; Rongjun Man; Haibo Wang; Jianfeng Li
Journal:  Front Mol Neurosci       Date:  2018-11-12       Impact factor: 5.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.